Skip to main content
Equibles
RNA logo

RNA · Atrium Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track RNA — free

Use RNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.50 -0.46 (-5.78%) At close · Nov 12
Russell 2000 member Rebalance outlook locked
Market Cap
$128.29M
Shares
21.57M
Volume · Nov 12 294.72K Avg daily vol (3M) 288.66K

Atrium Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Atrium Therapeutics, Inc. (RNA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

Embed Atrium Therapeutics, Inc. earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    
    
    


        

    

        

            

                Key facts
                    
                        CIK
                        2093101
                    
                    
                        CUSIP
                        04965N104
                    
                    
                        13F (30d)
                        61 filings
                        61 filers
                    
                    
                    
                         Visit website
                        
                    
                    
                         Investor relations